J. Dupas

Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study

P. Varlet, I. Iwanicki-Caron, C. Elie, 2017, Journal of Crohn's & colitis.

Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.

J. Ledent, P. Varlet, I. Iwanicki-Caron, 2018, Inflammatory bowel diseases.

Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis

P. Ducrotte, M. Antonietti, E. Hachulla, 2014, Alimentary pharmacology & therapeutics.

Innate mucosal‐associated invariant T (MAIT) cells are activated in inflammatory bowel diseases

O. Lantz, P. Marcelo, M. Eoche, 2014, Clinical and experimental immunology.

Unusual complication of tuberous sclerosis complex

R. De Giorgio, R. Corinaldesi, V. Stanghellini, 2004, Gut.

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study

I. Iwanicki-Caron, F. Vasseur, G. Savoye, 2016, Gut.

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride

J. Belaiche, C. Roux, É. Lerebours, 2002, Alimentary pharmacology & therapeutics.

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study

R. Modigliani, P. Marteau, J. Cosnes, 2003, Alimentary pharmacology & therapeutics.